MaRS partners with Johnson & Johnson to fund human health innovations
Toronto-based commercialization hub MaRS Innovation has entered into a collaboration with Johnson & Johnson Innovation, and its affiliate Janssen Inc, to advance early-stage technologies related to human health in therapeutics, medical devices, and diagnostics. Under the terms of the three-year agreement, MaRS Innovation and the Johnson & Johnson Innovation Center in Boston, Mass. will jointly identify and fund high-potential opportunities emerging from research at MaRS Innovation's 16 member institutions, which include the University of Toronto and its teaching hospitals.
25 November 2013•2 mins read
